GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ember Therapeutics Inc (OTCPK:EMBT) » Definitions » Other Income (Minority Interest)

Ember Therapeutics (Ember Therapeutics) Other Income (Minority Interest) : $0.00 Mil (TTM As of Sep. 2015)


View and export this data going back to 2015. Start your Free Trial

What is Ember Therapeutics Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. Ember Therapeutics's Other Income (Minority Interest) for the three months ended in Sep. 2015 was $0.00 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Sep. 2015 was $0.00 Mil.


Ember Therapeutics Other Income (Minority Interest) Historical Data

The historical data trend for Ember Therapeutics's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ember Therapeutics Other Income (Minority Interest) Chart

Ember Therapeutics Annual Data
Trend Dec12 Dec13 Dec14
Other Income (Minority Interest)
- - -

Ember Therapeutics Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Other Income (Minority Interest) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ember Therapeutics Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ember Therapeutics  (OTCPK:EMBT) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Ember Therapeutics (Ember Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
135 East 57th Street, 24th Floor, New York, NY, USA, 10022
Ember Therapeutics Inc is engaged in the healthcare sector. It is a biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein-7 (BMP-7) and related family of BMPs, mutants, variants, novel formulations, and delivery technologies. It looks to develop regenerative medicines for disease modification of osteoarthritis, reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases such as chronic kidney disease and Alport Syndrome.

Ember Therapeutics (Ember Therapeutics) Headlines

From GuruFocus